{
    "summary": "The Biosimilar Red Tape Elimination Act amends the Public Health Service Act to improve requirements for determining the interchangeability of biosimilar biological products. It modifies sections regarding biosimilar product applications, interchangeability, and transition dates. The bill also mandates the Secretary to update existing guidance related to biosimilar approval and data requirements within 18 months of enactment.",
    "tags": [
        "Healthcare",
        "Consumer protection",
        "Technology regulation",
        "Bipartisanship"
    ],
    "category": "Healthcare & Public Health"
}